AP-23517

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameAP-23517
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAriad Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAriad Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A